Tag Archives: Corpus Striatum/metabolism/radionuclide imaging

Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators

Reeves SJ, Polling C, Stokes PRA, Lappin JM, Shotbolt PP, Mehta MA, Howes OD, Egerton A. Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators. Psychiatry Res. April 2012;202(1):60-64. Publication Date April 2012 How Analyze was Used “The transformed VOI map was used to sample…

Quantification of receptor-ligand binding potential in sub-striatal domains using probabilistic and template regions of interest

del Campo N, Tait RJ, Acosta-Cabronero J, Hong YT, Izquierdo-Garcia D, Smith R, Aigbirhio FI, Sahakian BJ, Müller U, Robbins TW, Fryer TD. Quantification of receptor-ligand binding potential in sub-striatal domains using probabilistic and template regions of interest. Neuroimage. March 2011;55(1):101-112. Publication Date March 2011 How Analyze was Used “Three-dimensional regions of interest were manually…

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study

Willeit M, Ginovart N, Graff A, Rusjan P, Vitcu I, Houle S, Seeman P, Wilson AA, Kapur S. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology. January 2008;33(2):279-289. Full Text – Open Access Publication Date January 2008 How Analyze was Used “For manual analysis,…

Microglial activation correlates with severity in Huntington disease: a clinical and PET study

Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology. June 2006;66(11):1638-1643. Publication Date June 2006 How Analyze was Used “The standard object map contained regions defined for hypothalamus, frontal, parietal, temporal, and occipital lobes…

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O’Malley S, Innis RB. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse. September 2001;41(4):275-284. Publication Date September 2001 How Analyze was Used “The accuracy of co-registration in the x and y…

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D [18F]dopa-PET study

Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, Dagher A, Jenkins IH, Friston KJ, Brooks DJ. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D [18F]dopa-PET study. Brain. September 1999;122 ( Pt 9):1637-1650. Full Text – Open Access Publication Date September 1999 How Analyze was Used…

Striatal [18F]dopa uptake in familial idiopathic dystonia

Playford ED, Fletcher NA, Sawle GV, Marsden CD, Brooks DJ. Striatal [18F]dopa uptake in familial idiopathic dystonia. Brain. October 1993;116 ( Pt 5):1191-1199. Publication Date October 1993 How Analyze was Used “Region of interest analysis was performed on SUN3/60 workstation using image analysis software (Analyze 3.0).” Keywords Adult Corpus Striatum/metabolism/radionuclide imaging Dihydroxyphenylalanine/pharmacokinetics Dystonia Musculorum Deformans/metabolism…

Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ. Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. February 1992;31(2):184-192. Publication Date February 1992 How Analyze was Used “Data…